Coforge Ltd Q4 FY2025 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/r6byei0hwxp089xrwe7bqz2q.pdf

Key Takeaways


Order Book & Large Deals

Sudhir Singh: "The Sabre deal was won against two of the largest SIs in the world. When I look at the final shortlist of four, two of the folks who were against us were two of the largest SIs that do play within our industry."

Margins & Profitability

Sudhir Singh: "Oh no, I do not think there is any risk at all to fiscal year 2027 getting to 200 crore. The intent will be to get there faster. We would be a little disappointed if it took us all of fiscal year 2027 end to scrape by to 2 billion dollars."

Vertical & Client Performance

Vertical / CohortTrendCommentary
BFS▲ StrongGrew 13.4% QoQ, leading sequential growth.
Travel▲ SolidUp 7.5% QoQ; FY26 outlook strong on bookings, pipeline, and demand in existing key accounts, though US travel is cautious on capacity.
Government (outside India)▲ GoodGrew 8.5% sequentially.
Other emerging verticals▼ DeclinedDown 8.3% QoQ, driven by a sharp spike in Q3 from PAT revenue that did not repeat; full-year growth was 67%, so no softness in the Cigniti portfolio.
Top 5 / Top 10 clients▼ Q4 dipDeclined 5.9% and 4.6% QoQ respectively after growing 13.5% and 14.4% in Q3; management expects "very robust growth" to return in coming quarters and through FY26.

Cigniti Integration & M&A

Saurabh Goel: "We believe that somewhere toward December to January is a timeframe when the merger should get consummated. But having said that, as far as we are concerned from a business standpoint and from operation standpoint, apart from the fact that there are two separate listed legal entities running, the business synergies, and the operational synergies have started flowing in already."

AI & Technology


Risks & Unresolved Items


Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growth"Very robust" growth expected in FY26 despite uncertain macrosFY26
Organic growth directionNext year should be better than current year on an organic basisFY26
EBIT expansionLarge part of journey from 13.2% to ~14% EBIT to be coveredFY26
Reported EBITDAReach 18%FY27
RevenueReach \$2 billion; management intends to get there faster and would be disappointed if it took all of FY27FY27
ESOP costDecline to ~100 bps of revenueH2 FY26
OCF to EBITDA67–70% on an ongoing basis, with normal H1/H2 seasonalityOngoing
Cigniti merger consummationShare swap cleared by exchanges, SEBI review underwayDecember–January
Top client cohort growth"Very robust growth" to return to top 5 and top 10 clientsComing quarters / FY26
Large deal velocityNumber and median size of large deals to continue increasing year on yearFY26

Key Metrics

MetricQ4 FY25
Revenue\$403.8 million (continued operations), 3.3% QoQ in USD and 3.4% QoQ in CC terms
Full-year revenue\$1.445 billion, 31.5% YoY in USD, 32% in CC terms
Adjusted EBITDA margin18.7%, expanded 100 bps QoQ
Reported EBITDA margin16.6% for full year FY25
EBIT margin13.2% exit margin, expanded 123 bps QoQ
Net cash₹4.33 crore at year-end, versus net debt of ₹0.98 crore at end of FY24
Operating cash flow to EBITDA108% in Q4 (excluding transaction expenses), 71% for full year excluding integration expenses
Order intake\$2,136 million in Q4; full-year order intake \$3.5 billion, up 75.1% YoY
Executable order book\$1.5 billion, up 47.7% YoY
Large deals signed5 in Q4, 14 in full year FY25
Headcount33,497, net addition of 403 during the quarter and 8,771 during the year
Utilization82% (includes trainees)
Last-twelve-month attrition10.9%
ESOP cost as percentage of revenue1.8%, down 33 bps QoQ; expected to decline to ~100 bps from H2 FY26